Navigation Links
Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
Date:8/19/2007

nies and biotechnology companies that give it access to complementary technologies or greater resources. These strategic partnerships provide the company with mutually beneficial opportunities to expand its product pipeline and address significant unmet medical needs. Additional information on Vical is available at http://www.vical.com.

Forward-Looking Statements

This press release contains forward-looking statements subject to risks and uncertainties that could cause actual results to differ materially from those projected, including: whether Vical or others will continue development of the company's pandemic influenza or CMV vaccine candidates, the HGF product candidate, Allovectin-7(R), the HIV vaccine candidate, the RapidResponse(TM) DNA vaccine platform, the company's Vaxfectin(TM) adjuvant, or any other product candidates being developed by Vical, its collaborators or licensees; whether Vical will begin human testing of its pandemic influenza vaccine as anticipated in the second half of 2007, if at all; whether AnGes will file for marketing approval in Japan; whether the HGF product candidate will be approved in Japan; whether the market for the HGF product will be significant; whether the CMV vaccine will achieve the safety and efficacy endpoints in the Phase 2 trial for stem cell transplant donors and recipients; whether Vical will be able to recruit patients into the AIMM trial as planned, if at all; whether the results from animal trials can be duplicated in human trials; whether the Phase 2b HIV vaccine trial will begin this year, if at all; whether the RapidResponse(TM) platform will produce several million doses of vaccines in a matter of days and overcome the time, capacity and cost challenges of manufacturing conventional vaccines; whether the company will receive all, if any, of the RapidResponse(TM) grant funding; whether the company's pandemic influenza or CMV vaccine candidates, the HGF
'/>"/>

SOURCE Vical

Copyright©2007 PR Newswire.

Page: 1 2 3 4 5 6

Related medicine technology :

1. Vaccine Can Prevent Cervical Cancer and Precancerous Lesions
2. Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix Provides Excellent Protection Against Lesions Caused by Most Common Cancer-Causing Virus Types
3. Vical Licensee AnGes MG Announces Positive Results of Phase 3 Angiogenesis Trial in Japan
4. Vical Interim Clinical Results Demonstrate Safety and Tolerability of Inovio Biomedicals Electroporation DNA Delivery Technology
5. Cervarix, the GSK Cervical Cancer Candidate Vaccine, Provides Sustained Immune Response in 100 Percent of Women up to 55 Years of Age
6. Vicals Vaxfectin Adjuvant With Needle-free Delivery Enhances DNA Vaccine Performance; Yields Antibody Responses Comparable to Electroporation Without Tolerability Issues
7. New England Journal of Medicine Publishes New Data on Gardasil, Mercks Cervical Cancer Vaccine
8. Cervarix, GSK Cervical Cancer Candidate Vaccine, Demonstrates 100 Percent Protection Against Precancerous Lesions Caused By Cancer-Causing Human Papillomavirus Types 16 & 18 for More Than Five Years
9. Vicals Vaxfectin Adjuvant Achieves Dose-Sparing Effect With Seasonal Influenza Vaccine
10. Nventa Announces Presentation of Positive HspE7 Data from NCI-Sponsored Clinical Trial in Cervical Dysplasia
11. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... N.Y. , Aug. 21, 2014  The board ... ), a leading provider of clinical trial imaging solutions, ... been named chief financial officer, effective immediately.  Mr. Groff ... since August 2013.  He joined VirtualScopics in January 2006 ... in February 2013. "When the board of ...
(Date:8/21/2014)... 2014  Cyberonics, Inc. (NASDAQ: CYBX ) today ... Quarterly highlights 1   Operating results ... first quarter of fiscal 2014, and other achievements, include: ... of 6.8%; , Strong international net sales of $13.2 ... , U.S. net product sales reached a new high ...
(Date:8/20/2014)... N.Y. , Aug. 20, 2014 ... today announced that after months of hard work ... finished the new Snorenz formulation and package design.  ... E and B-6 back into the product due ... as longer lasting effects.  Snorenz Nighttime will also ...
Breaking Medicine Technology:VirtualScopics, Inc. Names James Groff Chief Financial Officer 2VirtualScopics, Inc. Names James Groff Chief Financial Officer 3VirtualScopics, Inc. Names James Groff Chief Financial Officer 4Cyberonics Reports Fiscal 2015 First Quarter Results 2Cyberonics Reports Fiscal 2015 First Quarter Results 3Cyberonics Reports Fiscal 2015 First Quarter Results 4Cyberonics Reports Fiscal 2015 First Quarter Results 5Cyberonics Reports Fiscal 2015 First Quarter Results 6Cyberonics Reports Fiscal 2015 First Quarter Results 7Cyberonics Reports Fiscal 2015 First Quarter Results 8Cyberonics Reports Fiscal 2015 First Quarter Results 9Cyberonics Reports Fiscal 2015 First Quarter Results 10Cyberonics Reports Fiscal 2015 First Quarter Results 11Cyberonics Reports Fiscal 2015 First Quarter Results 12Cyberonics Reports Fiscal 2015 First Quarter Results 13Cyberonics Reports Fiscal 2015 First Quarter Results 14Cyberonics Reports Fiscal 2015 First Quarter Results 15Cyberonics Reports Fiscal 2015 First Quarter Results 16Northstar completes the first phase of its new retail strategy and prepares to ship reformulated Snorenz with all new packaging 2
... PositiveFriends.com, (http://www.positivefriends.com ), a new online support ... today announced its official,launch into the online social ... the result of two years of R&D and ... HIV/AIDS, Hepatitis, Herpes, and,HPV (Human Papilloma Virus) varying ...
... to show encouraging anti-tumor activity in,non- small cell lung cancer; Phase ... ... SAN FRANCISCO, Oct. 24 Exelixis, Inc.,(Nasdaq: EXEL ) ... inhibitor of EGFR, HER2 and VEGFR kinases, in previously untreated,clinically selected ...
Cached Medicine Technology:PositiveFriends.com Launches STD Social Networking Site Balancing Dating with Online Support Features 2Exelixis Reports XL647 Clinical Data at AACR-NCI-EORTC Conference 2Exelixis Reports XL647 Clinical Data at AACR-NCI-EORTC Conference 3Exelixis Reports XL647 Clinical Data at AACR-NCI-EORTC Conference 4Exelixis Reports XL647 Clinical Data at AACR-NCI-EORTC Conference 5
(Date:8/22/2014)... The New Jersey Institute for Food, ... University of New Jersey has joined forces with ... educate young people about health and nutrition in a ... both organizations. , The partnership will encompass quarterly custom ... and video communications. ChopChop Magazine features plenty of ...
(Date:8/22/2014)... 2014 (HealthDay News) -- The U.S. Drug Enforcement Administration ... painkillers containing hydrocodone, which has been tied to a ... The new restrictions would cover prescription narcotic drugs such ... in the same regulatory class as painkillers such as ... access to a three-month supply of the drug and ...
(Date:8/22/2014)... low levels of nicotine may reduce addiction without ... new study from the University of Waterloo. ... Cancer Epidemiology monitored the smoking behaviours of ... of cigarettes with markedly reduced nicotine levels. , ... of which have very similar levels of nicotine ...
(Date:8/22/2014)... The leather seat covers provided ... experts to meet customers’specific product needs. Recently, the company has ... . , The company wants to provide worldwide clients ... the seat cover industry for a long time. According to ... offered at promotional rates. Among all the new products, ...
(Date:8/22/2014)... 2014 AcousticSheep LLC participated in one ... – the first Color Run – otherwise known as the “Happiest ... 2014 and over 10,900 participants from Erie, surrounding areas, and even ... in one of the largest running events put on in Erie, ... the “Happiest 5K on the Planet.” The event took place on ...
Breaking Medicine News(10 mins):Health News:New Jersey Institute for Food, Nutrition & Health to Launch Innovative Partnership with Award-Winning Children’s Anti-Obesity Organization, ChopChop Kids 2Health News:New Jersey Institute for Food, Nutrition & Health to Launch Innovative Partnership with Award-Winning Children’s Anti-Obesity Organization, ChopChop Kids 3Health News:U.S. to Tighten Access to Certain Narcotic Painkillers 2Health News:U.S. to Tighten Access to Certain Narcotic Painkillers 3Health News:Smokers consume same amount of cigarettes regardless of nicotine levels 2Health News:Custom 1993-1996 Chevrolet Camaro Leather Seat Covers Now for Sale at Lseat.com 2Health News:RunPhones® Reveals Erie, PA Enthusiasm Impressed Color Run Director 2Health News:RunPhones® Reveals Erie, PA Enthusiasm Impressed Color Run Director 3
... , , - Ninety-minute Report ... SMILEY and NIGHTLY BUSINESS REPORT - , , ... a major address on healthcare to a joint session of Congress ... and NIGHTLY BUSINESS REPORT are collaborating to provide a timely and ...
... , , LOS ... Dr. Christina Restrepo has achieved diplomate status with the American College ... Restrepo graduated in 2003 from the University of Florida College of ... small animal medicine and surgery at the renowned Animal Medical Center ...
... , , Actuaries Urge President to ... WASHINGTON, Sept. 8 The American Academy of Actuaries ... is expecting there to be an increase in the number of people without ... According to last year,s Census Bureau estimates, nearly 46 million people were ...
... Only Hospital in Northern and Central California to ... REDWOOD CITY, Calif., Sept. 8 Sequoia Hospital announced that ... ablation procedures, making it the highest total volume A-Fib ablation ... Numerous medical journals and world-wide ablation center surveys have documented ...
... when disease will respond to cancer drug , TUESDAY, Sept. ... into whether certain aggressive cancers -- including those that attack ... certain anti-cancer drug. , The key appears to lie in ... 6 online issue of Nature Medicine . , Researchers ...
... diabetes in children, University of Iowa researchers have discovered ... and insulin secretion. The mechanism involves a protein called ... human heart arrhythmias. The findings, which ... Proceedings of the National Academy of Sciences , ...
Cached Medicine News:Health News:PBS Special on Health Care Reform 2Health News:PBS Special on Health Care Reform 3Health News:PBS Special on Health Care Reform 4Health News:Animal Dermatology Clinic Marina del Rey Announces Dr. Christina Restrepo, DVM Achieves Diplomate Status With the American College of Veterinary Dermatology 2Health News:Actuaries: Unemployment May Boost Number of Uninsured 2Health News:Sequoia Hospital Announces High Volume Cardiac Arrhythmia Program 2Health News:Sequoia Hospital Announces High Volume Cardiac Arrhythmia Program 3Health News:Team reveals molecular mechanism underlying a form of diabetes 2
... Keeler Galilean loupes are ideal ... when increased magnification and a large ... loupes are laser aligned, lightweight and ... ,Fixed working distance and superior depth ...
U tip irrigation-aspiration cannual designed for manual removal of 12 oclock cortex. 23 gauge thin wall irrigation and aspiration lines for maximum aspiration capabilities. Polished finish. Overall l...
... stools come with five legs for ... 18" to 25" (total vertical travel ... rubber castors. Comfortable, durable and fire ... as standard, other colors available by ...
Anterior Stromal Puncture Cannula, 25 g. For treatment of recurrent corneal erosion. Overall length 24 mm. 5/box....
Medicine Products: